A novel nomogram for predicting the risk of delayed onset lactogenesis II among women who delivered via cesarean section in China.

IF 1.2 4区 医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Women & Health Pub Date : 2025-02-27 DOI:10.1080/03630242.2025.2457643
Yingmo Tian, Yanping Zhao
{"title":"A novel nomogram for predicting the risk of delayed onset lactogenesis II among women who delivered via cesarean section in China.","authors":"Yingmo Tian, Yanping Zhao","doi":"10.1080/03630242.2025.2457643","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to develop a prognostic nomogram to predict the risk of delayed onset lactogenesis II (DOL II) in Chinese women who delivered via cesarean section. A total of 143 women who delivered via cesarean section in our hospital between June 2021 and May 2022 were retrospectively reviewed. A nomogram was constructed using the independent predictors extracted from the logistic regression analysis. Validation of the prognostic model was conducted using the concordance index, calibration curves and decision curve analyses (DCAs). Multivariate analyses revealed that the factors associated with DOL II after cesarean section were gestational weight gain (GWG), gestational hypertension, previous breastfeeding experience and previous insufficient lactation. The nomogram was constructed based on the above four factors. The area under the receiver operating characteristic curve was 0.801 in the validation set. The Youden index of the model was 0.49, with a sensitivity of 0.661 and a specificity of 0.829. The DCA indicated that our nomogram provided excellent positive net clinical benefits for predicting the risk of DOL II. This nomogram can provide a scientific basis for medical workers to promptly identify the risk of DOL II in women who have undergone cesarean section, prevent the occurrence of DOL II and improve the breastfeeding rate of mothers and the quality of life of newborns.</p>","PeriodicalId":23972,"journal":{"name":"Women & Health","volume":" ","pages":"1-10"},"PeriodicalIF":1.2000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Women & Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03630242.2025.2457643","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

This study aimed to develop a prognostic nomogram to predict the risk of delayed onset lactogenesis II (DOL II) in Chinese women who delivered via cesarean section. A total of 143 women who delivered via cesarean section in our hospital between June 2021 and May 2022 were retrospectively reviewed. A nomogram was constructed using the independent predictors extracted from the logistic regression analysis. Validation of the prognostic model was conducted using the concordance index, calibration curves and decision curve analyses (DCAs). Multivariate analyses revealed that the factors associated with DOL II after cesarean section were gestational weight gain (GWG), gestational hypertension, previous breastfeeding experience and previous insufficient lactation. The nomogram was constructed based on the above four factors. The area under the receiver operating characteristic curve was 0.801 in the validation set. The Youden index of the model was 0.49, with a sensitivity of 0.661 and a specificity of 0.829. The DCA indicated that our nomogram provided excellent positive net clinical benefits for predicting the risk of DOL II. This nomogram can provide a scientific basis for medical workers to promptly identify the risk of DOL II in women who have undergone cesarean section, prevent the occurrence of DOL II and improve the breastfeeding rate of mothers and the quality of life of newborns.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
本研究旨在建立一个预后提名图,以预测中国剖宫产产妇发生迟发性泌乳素生成Ⅱ(DOLⅡ)的风险。研究回顾性分析了 2021 年 6 月至 2022 年 5 月期间在我院进行剖宫产的 143 名产妇。利用从逻辑回归分析中提取的独立预测因素构建了一个提名图。利用一致性指数、校准曲线和决策曲线分析(DCA)对预后模型进行了验证。多变量分析表明,与剖宫产术后 DOL II 相关的因素有妊娠体重增加(GWG)、妊娠高血压、既往母乳喂养经历和既往泌乳不足。根据上述四个因素构建了提名图。验证集的接收者操作特征曲线下面积为 0.801。模型的尤登指数为 0.49,灵敏度为 0.661,特异度为 0.829。DCA 表明,我们的提名图在预测 DOL II 风险方面提供了极好的临床净效益。该提名图可为医务工作者及时识别剖宫产产妇发生 DOL II 的风险、预防 DOL II 的发生、提高产妇母乳喂养率和新生儿生活质量提供科学依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Women & Health
Women & Health Multiple-
CiteScore
2.70
自引率
0.00%
发文量
73
期刊介绍: Women & Health publishes original papers and critical reviews containing highly useful information for researchers, policy planners, and all providers of health care for women. These papers cover findings from studies concerning health and illness and physical and psychological well-being of women, as well as the environmental, lifestyle and sociocultural factors that are associated with health and disease, which have implications for prevention, early detection and treatment, limitation of disability and rehabilitation.
期刊最新文献
A novel nomogram for predicting the risk of delayed onset lactogenesis II among women who delivered via cesarean section in China. Women's experiences and challenges with tandem breastfeeding: a qualitative study. Analysis of harmful menstruation beliefs and practices: a systematic review. Women's experience and perspectives about physical therapy during pregnancy and after childbirth. Palmitoylethanolamide (Levagen+) for acute menstrual pain: a randomized, crossover, double-blind, placebo-controlled trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1